GlobeNewsWire
27 Mar 2026, 13:00 UTC · 27w ago
Verdict
Headline takes no side. We score TNDM −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Tandem Diabetes Care identified a malfunction in several insulin pumps that could stop insulin delivery and lead to hyperglycemia or hospitalization.
More negative than 99% of claims this week
The Portnoy Law Firm has initiated an investigation into possible securities fraud and may file a class action lawsuit against Tandem Diabetes Care.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 91% of claims this week
Tandem Diabetes Care notified affected customers of the pump flaw between July 22 and 24, 2025, prior to making the information public on August 7, 2025.
More negative than 86% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is under investigation for securities fraud following a major insulin pump malfunction and a significant stock price drop.
More negative than 85% of ticker scores this week
The company is being advised of a class action lawsuit.
More negative than 85% of ticker scores this week
The company is being advised of a class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−29.0%
Price agrees with the score
$16.55 vs $23.32 close before publication (Mar 26) · not market-adjusted
TNDM chart →
